Psychiatry and Neurology, Neurology · Boston, MA
NPI
1205000148
Since 2008
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
75 Francis St, Department of Neurology, Bwh
Boston, MA, 02115
Phone (617) 732-5500
Groups this clinician bills Medicare through
Medicare paid, 2024
$12K
167 services
Medicare patients, 2024
58
Average age 62
Drug cost, 2024
$2.3M
1,374 prescriptions
Company payments, 2025
$7,735
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tarun Singhal was code 99443 (telephone services), 63 times for 34 patients. In total Tarun Singhal billed 167 services in 7 codes, and Medicare paid $12K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-10-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99443 Telephone Services | Facility | 63 | 34 | $69.57 | $4,383 |
| 99214 Office E&M - Established | Facility | 62 | 40 | $70.39 | $4,364 |
| 99215 Office E&M - Established | Facility | 23 | 17 | $100.00 | $2,300 |
By year: 2022 $12K for 165 services; 2023 $12K for 164 services; 2024 $12K for 167 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tarun Singhal prescribed most often to Medicare patients was Baclofen, with 120 prescriptions and refills. In total Tarun Singhal wrote 1,374 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Baclofen Generic | 120 | 261 | 29 | $3,178 |
| Dalfampridine Er Dalfampridine | 113 | 125 | 14 | $30K |
| Modafinil Generic | 79 | 91 | Under 11 | $1,531 |
| Kesimpta Pen Ofatumumab | 71 | 74 | Under 11 | $657K |
| Clonazepam Generic | 68 | 80 | Under 11 | $509 |
| Gabapentin Generic | 67 | 111 | 16 | $1,069 |
| Tizanidine Hcl Generic | 58 | 108 | 15 | $1,380 |
| Methylphenidate Hcl Generic | 46 | 46 | Under 11 | $1,143 |
| Pregabalin Generic | 44 | 50 | Under 11 | $408 |
| Copaxone Glatiramer Acetate | 39 | 39 | Under 11 | $222K |
| Nurtec Odt Rimegepant Sulfate | 38 | 38 | 12 | $59K |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 30 | 30 | Under 11 | $1,669 |
| Panzyga Immun Glob G(Igg)-Ifas/Glycine | 28 | 28 | Under 11 | $86K |
| Trazodone Hcl Generic | 28 | 46 | Under 11 | $146 |
| Tecfidera Dimethyl Fumarate | 25 | 25 | Under 11 | $229K |
Brand drugs: 299 claims; generic drugs: 1,075 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tarun Singhal $7,735 ($507 in general payments such as food, travel and fees and $7,228 for research) from 8 companies. The largest payer was Novartis Pharmaceuticals Corporation with $7,307.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.